T cells in SARS-CoV-2 infection and vaccination
While antibodies garner the lion’s share of attention in SARS-CoV-2 immunity, cellular immunity (T cells) may be equally, if not more important, in controlling infection. Both CD8 + and CD4 + T cells are elicited earlier and are associated with milder disease, than antibodies, and T-cell activation...
Main Author: | Arthur Young |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2022-08-01
|
Series: | Therapeutic Advances in Vaccines and Immunotherapy |
Online Access: | https://doi.org/10.1177/25151355221115011 |
Similar Items
-
Children’s SARS-CoV-2 Infection and Their Vaccination
by: Sneh Lata Gupta, et al.
Published: (2023-02-01) -
Association of SARS-CoV-2 Vaccinations with SARS-CoV-2 Infections, ICU Admissions and Deaths in Greece
by: Foteini Malli, et al.
Published: (2022-02-01) -
Vaccines and Therapies in Development for SARS-CoV-2 Infections
by: David Wu, et al.
Published: (2020-06-01) -
Diabetes and coronavirus infections (SARS-CoV, MERS-CoV, and SARS-CoV-2)
by: Azadeh Haghi Navand, et al.
Published: (2020-01-01) -
Neutralisation of SARS-CoV-2 lineage P.1 by antibodies elicited through natural SARS-CoV-2 infection or vaccination with an inactivated SARS-CoV-2 vaccine: an immunological study
by: Souza, WM, et al.
Published: (2021)